annual accounts payable:
$23.53M-$18.14M(-43.53%)Summary
- As of today (July 1, 2025), TVTX annual accounts payable is $23.53 million, with the most recent change of -$18.14 million (-43.53%) on December 31, 2024.
- During the last 3 years, TVTX annual accounts payable has risen by +$8.39 million (+55.40%).
- TVTX annual accounts payable is now -43.53% below its all-time high of $41.67 million, reached on December 31, 2023.
Performance
TVTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$15.37M-$8.16M(-34.67%)Summary
- As of today (July 1, 2025), TVTX quarterly accounts payable is $15.37 million, with the most recent change of -$8.16 million (-34.67%) on March 31, 2025.
- Over the past year, TVTX quarterly accounts payable has dropped by -$1.35 million (-8.08%).
- TVTX quarterly accounts payable is now -63.11% below its all-time high of $41.67 million, reached on December 31, 2023.
Performance
TVTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TVTX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.5% | -8.1% |
| 3 y3 years | +55.4% | -16.6% |
| 5 y5 years | -11.6% | +54.3% |
TVTX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.5% | +55.4% | -63.1% | +29.8% |
| 5 y | 5-year | -43.5% | +94.0% | -63.1% | +163.7% |
| alltime | all time | -43.5% | >+9999.0% | -63.1% | >+9999.0% |
TVTX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $15.37M(-34.7%) |
| Dec 2024 | $23.53M(-43.5%) | $23.53M(+1.5%) |
| Sep 2024 | - | $23.20M(-10.2%) |
| Jun 2024 | - | $25.84M(+54.5%) |
| Mar 2024 | - | $16.73M(-59.9%) |
| Dec 2023 | $41.67M(+141.0%) | $41.67M(+68.5%) |
| Sep 2023 | - | $24.74M(+24.2%) |
| Jun 2023 | - | $19.91M(+19.1%) |
| Mar 2023 | - | $16.73M(-3.3%) |
| Dec 2022 | $17.29M(+14.2%) | $17.29M(+23.4%) |
| Sep 2022 | - | $14.01M(+18.2%) |
| Jun 2022 | - | $11.85M(-35.7%) |
| Mar 2022 | - | $18.43M(+21.7%) |
| Dec 2021 | $15.14M(+24.8%) | $15.14M(+159.8%) |
| Sep 2021 | - | $5.83M(-30.1%) |
| Jun 2021 | - | $8.34M(-44.4%) |
| Mar 2021 | - | $15.01M(+23.7%) |
| Dec 2020 | $12.13M(-54.4%) | $12.13M(+28.7%) |
| Sep 2020 | - | $9.43M(-7.5%) |
| Jun 2020 | - | $10.20M(+2.3%) |
| Mar 2020 | - | $9.97M(-62.6%) |
| Dec 2019 | $26.61M(+282.7%) | $26.61M(+92.4%) |
| Sep 2019 | - | $13.83M(+10.5%) |
| Jun 2019 | - | $12.52M(+64.1%) |
| Mar 2019 | - | $7.63M(+9.7%) |
| Dec 2018 | $6.95M(-63.3%) | $6.95M(-25.3%) |
| Sep 2018 | - | $9.31M(+18.7%) |
| Jun 2018 | - | $7.85M(-16.7%) |
| Mar 2018 | - | $9.42M(-50.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $18.94M(+151.8%) | $18.94M(+157.0%) |
| Sep 2017 | - | $7.37M(-18.8%) |
| Jun 2017 | - | $9.08M(+94.3%) |
| Mar 2017 | - | $4.67M(-37.9%) |
| Dec 2016 | $7.52M(-1.5%) | $7.52M(+145.3%) |
| Sep 2016 | - | $3.07M(-51.2%) |
| Jun 2016 | - | $6.29M(+35.2%) |
| Mar 2016 | - | $4.65M(-39.2%) |
| Dec 2015 | $7.64M(+7.2%) | $7.64M(+56.1%) |
| Sep 2015 | - | $4.89M(+2.4%) |
| Jun 2015 | - | $4.78M(-19.2%) |
| Mar 2015 | - | $5.91M(-17.0%) |
| Dec 2014 | $7.12M(+100.5%) | $7.12M(-36.9%) |
| Sep 2014 | - | $11.29M(+6.2%) |
| Jun 2014 | - | $10.63M(+86.0%) |
| Mar 2014 | - | $5.71M(+60.7%) |
| Dec 2013 | $3.55M(+247.3%) | $3.55M(+106.4%) |
| Sep 2013 | - | $1.72M(+20.7%) |
| Jun 2013 | - | $1.43M(+194.1%) |
| Mar 2013 | - | $484.70K(>+9900.0%) |
| Dec 2012 | $1.02M(>+9900.0%) | - |
| Nov 2012 | - | $800.00(0.0%) |
| Aug 2012 | - | $800.00(0.0%) |
| May 2012 | - | $800.00(0.0%) |
| Feb 2012 | - | $800.00(0.0%) |
| Feb 2012 | $800.00(0.0%) | - |
| Nov 2011 | - | $800.00(0.0%) |
| Aug 2011 | - | $800.00(0.0%) |
| Feb 2011 | $800.00 | $800.00 |
FAQ
- What is Travere Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Travere Therapeutics?
- What is Travere Therapeutics annual accounts payable year-on-year change?
- What is Travere Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Travere Therapeutics?
- What is Travere Therapeutics quarterly accounts payable year-on-year change?
What is Travere Therapeutics annual accounts payable?
The current annual accounts payable of TVTX is $23.53M
What is the all time high annual accounts payable for Travere Therapeutics?
Travere Therapeutics all-time high annual accounts payable is $41.67M
What is Travere Therapeutics annual accounts payable year-on-year change?
Over the past year, TVTX annual accounts payable has changed by -$18.14M (-43.53%)
What is Travere Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TVTX is $15.37M
What is the all time high quarterly accounts payable for Travere Therapeutics?
Travere Therapeutics all-time high quarterly accounts payable is $41.67M
What is Travere Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TVTX quarterly accounts payable has changed by -$1.35M (-8.08%)